CNS Pharmaceuticals (CNSP) Cash & Equivalents (2018 - 2025)
CNS Pharmaceuticals (CNSP) reported Cash & Equivalents of $7.2 million for Q4 2025, up 11.4% from $6.46 million a year earlier but down 27.0% from the prior quarter.
Powered by 
Analysis
CNS Pharmaceuticals (CNSP) Cash & Equivalents (2018 - 2025) Analysis & Trends
Dating back to Q4 2018, CNS Pharmaceuticals' Cash & Equivalents record includes 29 quarters.
- Cash & Equivalents has a five-year compound annual growth rate of -12.5% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $6.46 million in FY2024, $548,721 in FY2023 (-94.5%), $10.06 million in FY2022 (+100.9%) and $5 million in FY2021 (-64.4%).
- Five-year quarterly Cash & Equivalents spans a low of $548,721 in Q4 2023 and a high of $13.05 million in Q1 2025.
- Year over year, Cash & Equivalents has now increased in each of the last three quarters, with growth averaging 213.9% over the last six quarters.
- The high point for year-over-year Cash & Equivalents in five years was Q2 2025 (growth of 713.2%); the low point was Q4 2023 (a decline of 94.5%).
- Per Business Quant data, the three quarters before Q4 2025 came in at $9.86 million (Q3 2025), $12.13 million (Q2 2025) and $13.05 million (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | CNS Pharmaceuticals | 2.36 Mn | -39.88 Mn | - | 7.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 7.20 Mn |
| Sep 30, 2025 | 9.86 Mn |
| Jun 30, 2025 | 12.13 Mn |
| Mar 31, 2025 | 13.05 Mn |
| Dec 31, 2024 | 6.46 Mn |
| Sep 30, 2024 | 6.97 Mn |
| Jun 30, 2024 | 1.49 Mn |
| Mar 31, 2024 | 815,226.00 |
| Dec 31, 2023 | 548,721.00 |
| Sep 30, 2023 | 909,547.00 |
| Jun 30, 2023 | 4.28 Mn |
| Mar 31, 2023 | 5.11 Mn |
| Dec 31, 2022 | 10.06 Mn |
| Sep 30, 2022 | 7.03 Mn |
| Jun 30, 2022 | 8.96 Mn |
| Mar 31, 2022 | 12.44 Mn |
| Dec 31, 2021 | 5.00 Mn |
| Sep 30, 2021 | 8.33 Mn |
| Jun 30, 2021 | 6.89 Mn |
| Mar 31, 2021 | 11.08 Mn |
API Access
CNS Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CNSP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "CNSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=CNSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();